"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about ZOMETA
• Ask Community about ZOMETA
• ZOMETA Usage
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

ZOMETA Safety Questions, ZOMETA Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about ZOMETA. Our extensive database of ZOMETA adverse events and ZOMETA warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about ZOMETA

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

ZOMETA Safety Reports

Total ZOMETA reports: 2029.
ZOMETA FDA safety alerts: 2004 2005 2007 .
Reported deaths: 155    Reported hospitalizations: 431.
Take ZOMETA Side Effects Survey or Share Your ZOMETA Story. ZOMETA Usage.

Showing 1-75 of 2029 Next >

Physician from UNITED KINGDOM reported ZOMETA problem on Jan 15, 2007. Female patient, 69 years of age, weighting 187.4 lb, was diagnosed with multiple myeloma, hyperthyroidism, hypertension and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone disorder, osteonecrosis, tooth extraction. ZOMETA dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, ATENOLOL, BENDROFLUAZIDE. Patient recovered.

ZOMETA problem was reported by a Pharmacist from JAPAN on Jan 15, 2007. Male patient, 60 years of age, was diagnosed with bone lesion and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone disorder, dental examination abnormal, device malfunction, gingival recession, oral mucosal exfoliation. ZOMETA dosage: 4 MG, UNK. During the same period patient was treated with AREDIA, HYPEN, PREDNISOLONE, MAGMITT KENEI, GASTER, PURSENNID, GEBEN. Patient recovered.

Physician from GERMANY reported ZOMETA problem on Jan 17, 2007. Female patient, 64 years of age, was diagnosed with multiple myeloma and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: dental operation, osteonecrosis, sequestrectomy, tooth extraction. ZOMETA dosage: unknown. Patient recovered.

ZOMETA problem was reported by a Consumer or non-health professional from FRANCE on Jan 15, 2007. Female patient, 79 years of age, was diagnosed with metastases to bone, breast cancer metastatic and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteolysis, osteonecrosis, pain in jaw. ZOMETA dosage: 4 MG, QMO. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ZOMETA problem on Jan 17, 2007. Female patient, 63 years of age, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: dental operation, impaired healing, osteolysis, osteonecrosis, swelling, tooth extraction. ZOMETA dosage: unknown. During the same period patient was treated with ARIMIDEX, ETILEFRINE. Patient recovered.

ZOMETA problem was reported by a Consumer or non-health professional from FRANCE on Jan 15, 2007. Female patient, 48 years of age, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone fistula, osteitis, osteonecrosis, pain in jaw, wound debridement. ZOMETA dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported ZOMETA problem on Jan 15, 2007. Female patient, 55 years of age, was diagnosed with metastases to bone, breast cancer metastatic and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, surgery, tooth extraction. ZOMETA dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FASLODEX. Patient was hospitalized. Patient recovered.

ZOMETA problem was reported by a Physician from GERMANY on Jan 15, 2007. Female patient was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteolysis, osteonecrosis. ZOMETA dosage: 4 MG, UNK. During the same period patient was treated with ARIMIDEX, TAMOXIFEN CITRATE. Patient recovered.

Health Professional from UNITED STATES reported ZOMETA problem on Jan 16, 2007. Male patient, 64 years of age, was diagnosed with multiple myeloma and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: pain, pain in jaw. ZOMETA dosage: 4MG Q4WK. Patient recovered.

ZOMETA problem was reported by a Consumer or non-health professional from FRANCE on Jan 16, 2007. Male patient, 75 years of age, was diagnosed with metastases to bone, neoplasm malignant and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, tooth extraction, toothache. ZOMETA dosage: 4 MG, QMO. During the same period patient was treated with GEMZAR. Patient recovered.

Physician from GERMANY reported ZOMETA problem on Jan 16, 2007. Female patient, 62 years of age, weighting 149.9 lb, was diagnosed with osteolysis and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: dental discomfort, osteonecrosis. ZOMETA dosage: 4 MG, QMO. During the same period patient was treated with BONDRONAT. Patient recovered.

ZOMETA problem was reported by a Physician from AUSTRALIA on Jan 16, 2007. Female patient, 72 years of age, was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: dry eye, gingival pain, impaired healing, oral mucosal blistering, osteonecrosis, tooth disorder, tooth extraction. ZOMETA dosage: unknown. During the same period patient was treated with STEROIDS NOS. Patient recovered.

Pharmacist from JAPAN reported ZOMETA problem on Jan 22, 2007. Male patient, 50 years of age, was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: pyrexia. ZOMETA dosage: unknown. Patient died.

ZOMETA problem was reported by a Physician from GERMANY on Jan 17, 2007. Female patient was diagnosed with cervix carcinoma and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: fistula, jaw operation, osteitis, osteonecrosis, primary sequestrum, tooth extraction, wound debridement. ZOMETA dosage: unknown. During the same period patient was treated with AREDIA. Patient recovered.

Consumer or non-health professional from GERMANY reported ZOMETA problem on Jan 17, 2007. Male patient, 61 years of age, was diagnosed with multiple myeloma and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone lesion, clavicle fracture, dental treatment, eating disorder, exostosis, gamma-glutamyltransferase increased, haemoglobin decreased, jaw operation, malignant neoplasm progression. ZOMETA dosage: 4 MG, QMO. Patient was hospitalized. Patient recovered.

ZOMETA problem was reported by a Consumer or non-health professional from FRANCE on Jan 15, 2007. Female patient, 71 years of age, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: gingival bleeding, impaired healing, mastication disorder, osteonecrosis, osteosclerosis, tooth abscess, tooth loss, toothache. ZOMETA dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ZOMETA problem on Jan 15, 2007. Male patient, 64 years of age, was diagnosed with prostate cancer and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone disorder, dental operation, dental treatment, osteonecrosis, promotion of wound healing, tooth extraction. ZOMETA dosage: 4 MG, QMO. During the same period patient was treated with TAXOTERE, PREDNISOLONE. Patient was hospitalized. Patient recovered.

ZOMETA problem was reported by a Physician from GERMANY on Jan 15, 2007. Male patient, 63 years of age, weighting 172.0 lb, was diagnosed with multiple myeloma and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: chronic sinusitis, computerised tomogram abnormal, dental operation, osteomyelitis, osteonecrosis. ZOMETA dosage: 4 MG, UNK. Patient recovered.

Physician from GERMANY reported ZOMETA problem on Jan 15, 2007. Female patient, 62 years of age, was diagnosed with breast cancer and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: dental operation, osteonecrosis. ZOMETA dosage: 4 MG, UNK. During the same period patient was treated with TAMOXIFEN CITRATE. Patient recovered.

ZOMETA problem was reported by a Physician from GERMANY on Jan 15, 2007. Male patient, 72 years of age, weighting 176.4 lb, was diagnosed with prostate cancer and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: dental operation, osteomyelitis, osteonecrosis. ZOMETA dosage: 4 MG, UNK. Patient recovered.

Physician from GERMANY reported ZOMETA problem on Jan 15, 2007. Female patient, 81 years of age, weighting 121.3 lb, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: dental treatment, jaw disorder, x-ray abnormal. ZOMETA dosage: 4 MG, QMO. Patient recovered.

ZOMETA problem was reported by a Consumer or non-health professional from FRANCE on Jan 16, 2007. Female patient, 48 years of age, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, periodontal disease, tooth extraction, toothache. ZOMETA dosage: unknown. During the same period patient was treated with AREDIA, CLASTOBAN. Patient was hospitalized. Patient recovered.

Physician from AUSTRIA reported ZOMETA problem on Jan 17, 2007. Female patient, 66 years of age, weighting 116.8 lb, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: jaw operation, osteonecrosis, sinusitis, tooth extraction. ZOMETA dosage: 3-4 MG, EVERY 21 DAYS. During the same period patient was treated with TRASTUZUMAB, EXEMESTANE. Patient recovered.

ZOMETA problem was reported by a Consumer or non-health professional from FRANCE on Jan 16, 2007. Female patient, 71 years of age, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: induration, jaw disorder, osteitis, pain in jaw, sequestrectomy. ZOMETA dosage: unknown. During the same period patient was treated with AREDIA. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported ZOMETA problem on Jan 16, 2007. Male patient, 83 years of age, was diagnosed with neoplasm prostate and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, osteosclerosis, pain in jaw, sinusitis, tooth disorder, toothache. ZOMETA dosage: unknown. Patient was hospitalized. Patient recovered.

ZOMETA problem was reported by a Consumer or non-health professional from FRANCE on Jan 16, 2007. Female patient, 50 years of age, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, tooth extraction. ZOMETA dosage: 4 MG, QMO. During the same period patient was treated with TAXOL, AVASTIN, CORTICOSTEROIDS. Patient recovered.

Physician from GERMANY reported ZOMETA problem on Jan 17, 2007. Female patient was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, radicular cyst. ZOMETA dosage: 4 MG, UNK. During the same period patient was treated with AREDIA, TAMOXIFEN CITRATE, ARIMIDEX. Patient recovered.

ZOMETA problem was reported by a Physician from BELGIUM on Jan 18, 2007. Male patient, 71 years of age, weighting 154.3 lb, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, tooth extraction. ZOMETA dosage: 4 MG, MONTHLY. During the same period patient was treated with DAFALGAN, BRUFEN, ZOLPIDEM TARTRATE, STEOVIT D, TARCEVA, TRANSTEC. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOMETA problem on Jan 18, 2007. Female patient, 59 years of age, was diagnosed with breast cancer, herpes virus infection and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: anxiety, injury, osteomyelitis, osteonecrosis, pain, sinus disorder, surgery, swelling, tooth extraction. ZOMETA dosage: 4 MG MONTHLY. During the same period patient was treated with NAVELBINE, COUMADIN, FAMVIR, NEXIUM, EVISTA, DETROL, TRAZODONE, CLONAZEPAM. Patient recovered.

ZOMETA problem was reported by a Physician from BELGIUM on Jan 18, 2007. Female patient, 55 years of age, weighting 103.6 lb, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, tooth extraction. ZOMETA dosage: 4 MG, MONTHLY. During the same period patient was treated with TAXOTERE, XELODA. Patient recovered.

Physician from BRAZIL reported ZOMETA problem on Jan 18, 2007. Female patient, 54 years of age, was diagnosed with breast cancer and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone disorder, dental implantation, dental operation, osteonecrosis, wound debridement. ZOMETA dosage: unknown. Patient recovered.

ZOMETA problem was reported by a Consumer or non-health professional from FRANCE on Jan 22, 2007. Female patient, 68 years of age, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: abscess drainage, abscess oral, osteonecrosis. ZOMETA dosage: 4 MG, UNK. During the same period patient was treated with TAXOTERE, CORTICOSTEROID NOS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOMETA problem on Jan 22, 2007. Female patient, 54 years of age, weighting 140.0 lb, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: anaemia, anxiety, back pain, blood creatinine increased, bone disorder, bone lesion, bone scan abnormal, cervical spinal stenosis, compression fracture. ZOMETA dosage: 4 MG EVERY 3-4 WEEKS. During the same period patient was treated with PROTONIX, ELAVIL, LIPITOR, FLEXERIL, ADRIAMYCIN PFS, CYTOXAN, FLUOROURACIL, ALOXI. Patient recovered.

ZOMETA problem was reported by a Physician from BELGIUM on Jan 18, 2007. Female patient, 56 years of age, weighting 187.4 lb, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: impaired healing, osteonecrosis, tooth extraction. ZOMETA dosage: 4 MG, MONTHLY. During the same period patient was treated with OMEPRAZOLE, FEMARA, STEOVIT D, BIOMAGNESIN. Patient recovered.

Physician from BELGIUM reported ZOMETA problem on Jan 18, 2007. Female patient, 59 years of age, weighting 116.8 lb, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone debridement, impaired healing, osteonecrosis, tooth extraction. ZOMETA dosage: 4 MG, MONTHLY. During the same period patient was treated with ULTRA KALIUM, STEOVIT D, ZOLPIDEM TARTRATE, XELODA. Patient recovered.

ZOMETA problem was reported by a Physician from BELGIUM on Jan 18, 2007. Female patient, 61 years of age, weighting 156.5 lb, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, tooth extraction. ZOMETA dosage: 4 MG, MONTHLY. During the same period patient was treated with VOLTAREN, VALIUM, INDOCID RETARD, EPISAM, MAGNESIUM, VITAMIN B CAP, MEDIAVEN, MS CONTIN. Patient recovered.

Physician from GERMANY reported ZOMETA problem on Jan 22, 2007. Male patient, 73 years of age, was diagnosed with prostate cancer metastatic and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, tooth extraction. ZOMETA dosage: 4 MG, QMO. During the same period patient was treated with ENANTONE. Patient recovered.

ZOMETA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 19, 2007. Female patient, 65 years of age, was diagnosed with bone neoplasm malignant, metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: actinomycosis, bone debridement, bone disorder, breath odour, dental fistula, gingivitis, infection, osteonecrosis, pain. ZOMETA dosage: unknown. During the same period patient was treated with AREDIA. Patient recovered.

Health Professional from UNITED STATES reported ZOMETA problem on Jan 19, 2007. Male patient, 60 years of age, weighting 210.0 lb, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. ZOMETA dosage: 4MG QMO. During the same period patient was treated with ERBITUX. Patient recovered.

ZOMETA problem was reported by a Physician from BELGIUM on Jan 18, 2007. Female patient, 49 years of age, weighting 158.7 lb, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: infection, osteonecrosis, ulcer. ZOMETA dosage: 4 MG, MONTHLY. During the same period patient was treated with PALLADONE, ELTHYRONE, FELDENE, DURAGESIC, MEDROL, PARIET, FEMARA, DEPAKENE. Patient recovered.

Physician from FRANCE reported ZOMETA problem on Jan 18, 2007. Female patient, 54 years of age, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. ZOMETA dosage: unknown. Patient recovered.

ZOMETA problem was reported by a Physician from BELGIUM on Jan 18, 2007. Male patient, 79 years of age, weighting 114.6 lb, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. ZOMETA dosage: 4 MG, MONTHLY. During the same period patient was treated with LUCRIN, CASODEX, MEDROL, SERETIDE, FUROSEMIDE, SPIRIVA. Patient recovered.

Consumer or non-health professional from ITALY reported ZOMETA problem on Jan 19, 2007. Female patient was diagnosed with breast cancer and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: haemorrhage, oral pain, osteonecrosis, surgery, tooth disorder. ZOMETA dosage: 4 MG, EVERY 1 MONTH. Patient recovered.

ZOMETA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 26, 2007. Female patient, 62 years of age, weighting 140.0 lb, was diagnosed with metastases to bone, breast cancer and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: anaemia, aspiration pleural cavity, back pain, bone disorder, bone fistula, bruxism, chills, cough. ZOMETA dosage: 4 MG, UNK. During the same period patient was treated with AREDIA, ARIMIDEX, FLUOROURACIL, LEUCOVORIN CALCIUM, XELODA, TAXOTERE, MITOXANTRONE, NEULASTA. Patient was hospitalized. Patient died.

Pharmacist from UNITED STATES reported ZOMETA problem on Feb 01, 2007. Male patient, weighting 140.0 lb, was diagnosed with metastases to bone, non-small cell lung cancer and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. ZOMETA dosage: 4MG EVERY 4 WEEKS IV DRIP. During the same period patient was treated with ETOPOSIDE, CARBOPLATIN, TAXOL, AVASTIN, ALOXI, DEXAMETHASONE, TAGAMET. Patient recovered.

ZOMETA problem was reported by a Physician from FRANCE on Jan 22, 2007. Female patient, 55 years of age, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone disorder, osteonecrosis, tooth extraction, tooth infection. ZOMETA dosage: 4 MG, QMO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOMETA problem on Jan 26, 2007. Male patient, 68 years of age, weighting 202.0 lb, was diagnosed with metastases to bone, prostate cancer, back pain and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone disorder, gingival disorder, herpes zoster, impaired healing, malignant neoplasm progression, nocturia, osteomyelitis, osteonecrosis. ZOMETA dosage: unknown. During the same period patient was treated with CASODEX, ZOLADEX, HYDROCORTISONE, VICODIN, VIOXX, LUPRON. Patient died.

ZOMETA problem was reported by a Physician from NETHERLANDS on Jan 23, 2007. Male patient, 46 years of age, was diagnosed with prostate cancer metastatic and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: muscle spasms, respiratory distress. ZOMETA dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported ZOMETA problem on Jan 22, 2007. Female patient, 77 years of age, was diagnosed with metastases to bone, breast cancer metastatic and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, poor personal hygiene, renal failure, tooth extraction. ZOMETA dosage: 4 MG, QMO. During the same period patient was treated with NAVELBINE, TAXOTERE. Patient recovered.

ZOMETA problem was reported by a Consumer or non-health professional from SWITZERLAND on Jan 23, 2007. Male patient, 73 years of age, was diagnosed with multiple myeloma and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone disorder, dental treatment, oral surgery, osteonecrosis, pain in jaw, tooth extraction. ZOMETA dosage: 4 MG, QMO. During the same period patient was treated with AREDIA, DEXAMETHASONE, VELCADE, NAVELBINE, THALIDOMIDE, CORTICOSTEROIDS. Patient recovered.

Consumer or non-health professional from SWITZERLAND reported ZOMETA problem on Jan 23, 2007. Male patient, 45 years of age, was diagnosed with multiple myeloma and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone debridement, bone disorder, bone trimming, dental treatment, osteonecrosis, pain in jaw, sinus disorder, tooth extraction. ZOMETA dosage: 4 MG EVERY 3-4 WEEKS. During the same period patient was treated with VELCADE, CORTICOSTEROIDS, AREDIA, HEMATOPOETIC PROGENITOR CELLS. Patient recovered.

ZOMETA problem was reported by a Consumer or non-health professional from SWITZERLAND on Jan 23, 2007. Female patient, 75 years of age, was diagnosed with metastases to bone, breast cancer, depression, gastrooesophageal reflux disease, pulmonary embolism and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: abscess jaw, bone disorder, bone trimming, dental treatment, incisional drainage, osteomyelitis, osteonecrosis, pain in jaw, tooth extraction. ZOMETA dosage: unknown. During the same period patient was treated with ARIMIDEX, SEROPRAM, NEXIUM, MARCUMAR, AREDIA, XELODA, DEXAMETHASONE, PREDNISONE. Patient was hospitalized and became disabled. Patient recovered.

Health Professional from UNITED KINGDOM reported ZOMETA problem on Jan 23, 2007. Male patient was diagnosed with prostate cancer and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: arthritis, arthropathy, knee operation, malaise. ZOMETA dosage: unknown. Patient was hospitalized. Patient recovered.

ZOMETA problem was reported by a Physician from UNITED STATES on Jan 24, 2007. Male patient, 72 years of age, was diagnosed with multiple myeloma and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone lesion, impaired healing, osteomyelitis, tooth extraction. ZOMETA dosage: unknown. Patient recovered.

Consumer or non-health professional from SWITZERLAND reported ZOMETA problem on Jan 23, 2007. Female patient, 70 years of age, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: abscess soft tissue, bone disorder, bone lesion, dental treatment, hypoaesthesia, incisional drainage, osteonecrosis, pain in jaw, tooth extraction. ZOMETA dosage: 4 MG EVERY 3 - 4 WEEKS. During the same period patient was treated with NOVANTRONE, XELODA, NAVELBINE, TAMOXIFEN CITRATE, ARIMIDEX, CORTICOSTEROIDS. Patient recovered.

ZOMETA problem was reported by a Physician from AUSTRALIA on Jan 25, 2007. Male patient, 65 years of age, was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. ZOMETA dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from AUSTRALIA reported ZOMETA problem on Jan 25, 2007. Female patient, 46 years of age, was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. ZOMETA dosage: unknown. Patient was hospitalized. Patient recovered.

ZOMETA problem was reported by a Consumer or non-health professional from FRANCE on Jan 24, 2007. Female patient, 78 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: abscess jaw, bone disorder, bone fistula, osteitis, osteonecrosis. ZOMETA dosage: 4 MG, QMO. Patient recovered.

Physician from FRANCE reported ZOMETA problem on Jan 23, 2007. Female patient, 65 years of age, was diagnosed with metastases to bone, metastases to lung, breast cancer metastatic and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone disorder, osteonecrosis. ZOMETA dosage: unknown. During the same period patient was treated with HERCEPTIN, CAELYX. Patient recovered.

ZOMETA problem was reported by a Physician from BRAZIL on Jan 25, 2007. Female patient, 56 years of age, was diagnosed with breast cancer and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone disorder, dental implantation, dental operation, osteonecrosis, wound debridement. ZOMETA dosage: 4 MG, EVERY 4 WEEKS. During the same period patient was treated with TAMOXIFEN CITRATE, FASLODEX. Patient recovered.

Physician from SPAIN reported ZOMETA problem on Jan 24, 2007. Female patient, 51 years of age, was diagnosed with breast cancer female and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, surgery. ZOMETA dosage: 4 MG, QMO. Patient recovered.

ZOMETA problem was reported by a Physician from SPAIN on Jan 24, 2007. Female patient, 77 years of age, was diagnosed with breast neoplasm and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteomyelitis, tooth extraction. ZOMETA dosage: 4 MG. Patient recovered.

Consumer or non-health professional from SWITZERLAND reported ZOMETA problem on Jan 23, 2007. Female patient, 70 years of age, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone lesion, dental treatment, osteonecrosis, pain in jaw, tooth extraction. ZOMETA dosage: unknown. During the same period patient was treated with TAMOXIFEN CITRATE, NOVANTRONE, XELODA, NAVELBINE, ARIMIDEX. Patient recovered.

ZOMETA problem was reported by a Physician from TURKEY on Jan 24, 2007. Female patient, 78 years of age, weighting 167.6 lb, was diagnosed with osteoporosis and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: dental discomfort, impaired healing, mouth ulceration, osteonecrosis, tooth extraction, wound debridement. ZOMETA dosage: unknown. During the same period patient was treated with ANASTROZOLE, TAMOXIFEN CITRATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from SWITZERLAND reported ZOMETA problem on Jan 23, 2007. Male patient, 45 years of age, was diagnosed with multiple myeloma and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone debridement, bone disorder, bone trimming, dental treatment, osteonecrosis, pain in jaw, sinus disorder, tooth extraction. ZOMETA dosage: 4 MG EVERY 3-4 WEEKS. During the same period patient was treated with VELCADE, CORTICOSTEROIDS, AREDIA, HEMATOPOETIC PROGENITOR CELLS. Patient recovered.

ZOMETA problem was reported by a Physician from GERMANY on Jan 24, 2007. Female patient, 85 years of age, was diagnosed with prophylaxis and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone disorder, candidiasis, dental caries, oral candidiasis, osteonecrosis, periodontitis, primary sequestrum, scintigraphy, single photon emission computerised tomogram abnormal. ZOMETA dosage: unknown. During the same period patient was treated with HERCEPTIN. Patient recovered.

Physician from TURKEY reported ZOMETA problem on Jan 23, 2007. Female patient, 49 years of age, weighting 156.5 lb, was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood glucose increased, bone lesion, hepatic function abnormal, osteomyelitis, swelling, wound debridement. ZOMETA dosage: unknown. During the same period patient was treated with FEMARA. Patient was hospitalized. Patient recovered.

ZOMETA problem was reported by a Physician from GERMANY on Jan 25, 2007. Female patient was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. ZOMETA dosage: 4 MG, QMO. Patient recovered.

Physician from JAPAN reported ZOMETA problem on Jan 26, 2007. Female patient, 59 years of age, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteomyelitis, swelling face, tooth extraction. ZOMETA dosage: 4 MG, UNK. Patient recovered.

ZOMETA problem was reported by a Physician from GERMANY on Jan 25, 2007. Male patient was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: abscess jaw. ZOMETA dosage: 4 MG, QMO. Patient recovered.

Physician from GERMANY reported ZOMETA problem on Jan 25, 2007. Female patient, 75 years of age, was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. ZOMETA dosage: 4 MG, QMO. Patient recovered.

ZOMETA problem was reported by a Consumer or non-health professional from GERMANY on Jan 25, 2007. Female patient, 75 years of age, was diagnosed with multiple myeloma and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: actinomycosis, bone disorder, condition aggravated, dental alveolar anomaly, dental fistula, dental operation, haemoglobin decreased, histology abnormal. ZOMETA dosage: unknown. During the same period patient was treated with ASPIRIN. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported ZOMETA problem on Jan 25, 2007. Female patient, 60 years of age, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone disorder, dental caries, impaired healing. ZOMETA dosage: 4 MG, ONCE/SINGLE. During the same period patient was treated with HERCEPTIN, AREDIA. Patient recovered.

ZOMETA problem was reported by a Health Professional from UNITED STATES on Feb 05, 2007. Male patient, 40 years of age, weighting 231.5 lb, was diagnosed with brain neoplasm, osteoporosis and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: confusional state, mental status changes, urinary incontinence. ZOMETA dosage: 4MG Q12 WEEKS IV. During the same period patient was treated with ZOLOFT, COUMADIN, POTASSIUM CHLORIDE, DILANTIN, DEXAMETHASONE, PEPCID, ATIVAN. Patient was hospitalized. Patient died on 01/31/2007.

Consumer or non-health professional from AUSTRIA reported ZOMETA problem on Jan 29, 2007. Female patient was diagnosed with osteoporosis and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: fall, pelvic fracture, pelvic pain. ZOMETA dosage: 4 MG, UNK. During the same period patient was treated with AREDIA. Patient recovered.

Showing 1-75 of 2029 Next >

Ask Our Patient Community about ZOMETA
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate) Oxaliplatin Oxcarbazepine back to top P Pacerone (amiodarone) Palifermin Paliperidone Pamidronate Panitumumab Panretin Gel (alitretinoin) Pantoprazole Paricalcitol Paroxetine Paxil (paroxetine)